These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10479053)

  • 1. Role of HLA-G versus HLA-E on NK function: HLA-G is able to inhibit NK cytolysis by itself.
    Khalil-Daher I; Riteau B; Menier C; Sedlik C; Paul P; Dausset J; Carosella ED; Rouas-Freiss N
    J Reprod Immunol; 1999 Jul; 43(2):175-82. PubMed ID: 10479053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition.
    Riteau B; Menier C; Khalil-Daher I; Martinozzi S; Pla M; Dausset J; Carosella ED; Rouas-Freiss N
    Int Immunol; 2001 Feb; 13(2):193-201. PubMed ID: 11157852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-G1-transfected K562 cells do not inhibit NK-cell-mediated lysis in europium release cytotoxicity assay.
    Sapak M; Buc M
    Bratisl Lek Listy; 2003; 104(10):300-4. PubMed ID: 15055728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?
    Rouas-Freiss N; Marchal RE; Kirszenbaum M; Dausset J; Carosella ED
    Proc Natl Acad Sci U S A; 1997 May; 94(10):5249-54. PubMed ID: 9144223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
    Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCMV glycoprotein US6 mediated inhibition of TAP does not affect HLA-E dependent protection of K-562 cells from NK cell lysis.
    Ulbrecht M; Hofmeister V; Yüksekdag G; Ellwart JW; Hengel H; Momburg F; Martinozzi S; Reboul M; Pla M; Weiss EH
    Hum Immunol; 2003 Feb; 64(2):231-7. PubMed ID: 12559625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer.
    Llano M; Lee N; Navarro F; García P; Albar JP; Geraghty DE; López-Botet M
    Eur J Immunol; 1998 Sep; 28(9):2854-63. PubMed ID: 9754572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-E and HLA-G expression on porcine endothelial cells inhibit xenoreactive human NK cells through CD94/NKG2-dependent and -independent pathways.
    Sasaki H; Xu XC; Mohanakumar T
    J Immunol; 1999 Dec; 163(11):6301-5. PubMed ID: 10570324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the leader peptide sequence of the HLA-E gene up-regulates its expression and down-regulates natural killer cell-mediated swine endothelial cell lysis.
    Matsunami K; Miyagawa S; Nakai R; Yamada M; Shirakura R
    Transplantation; 2002 May; 73(10):1582-9. PubMed ID: 12042643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Hsp70 and HLA-E on the killing of leukemic blasts by cytokine/Hsp70 peptide-activated human natural killer (NK) cells.
    Stangl S; Gross C; Pockley AG; Asea AA; Multhoff G
    Cell Stress Chaperones; 2008; 13(2):221-30. PubMed ID: 18759005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An HLA-E single chain trimer inhibits human NK cell reactivity towards porcine cells.
    Crew MD; Cannon MJ; Phanavanh B; Garcia-Borges CN
    Mol Immunol; 2005 Jun; 42(10):1205-14. PubMed ID: 15829309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of HLA-E allele expression and different HLA-E ligand diversity for the regulation of NK cells.
    Maier S; Grzeschik M; Weiss EH; Ulbrecht M
    Hum Immunol; 2000 Nov; 61(11):1059-65. PubMed ID: 11137208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
    Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A
    Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1.
    Pérez-Villar JJ; Melero I; Navarro F; Carretero M; Bellón T; Llano M; Colonna M; Geraghty DE; López-Botet M
    J Immunol; 1997 Jun; 158(12):5736-43. PubMed ID: 9190923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porcine aortic endothelial cells transfected with HLA-G are partially protected from xenogeneic human NK cytotoxicity.
    Forte P; Matter-Reissmann UB; Strasser M; Schneider MK; Seebach JD
    Hum Immunol; 2000 Nov; 61(11):1066-73. PubMed ID: 11137209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-E/human beta2-microglobulin transgenic pigs: protection against xenogeneic human anti-pig natural killer cell cytotoxicity.
    Weiss EH; Lilienfeld BG; Müller S; Müller E; Herbach N; Kessler B; Wanke R; Schwinzer R; Seebach JD; Wolf E; Brem G
    Transplantation; 2009 Jan; 87(1):35-43. PubMed ID: 19136889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effect of IFN-gamma and human cytomegalovirus protein UL40 in the HLA-E-dependent protection from NK cell-mediated cytotoxicity.
    Cerboni C; Mousavi-Jazi M; Wakiguchi H; Carbone E; Kärre K; Söderström K
    Eur J Immunol; 2001 Oct; 31(10):2926-35. PubMed ID: 11592068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.
    Pende D; Sivori S; Accame L; Pareti L; Falco M; Geraghty D; Le Bouteiller P; Moretta L; Moretta A
    Eur J Immunol; 1997 Aug; 27(8):1875-80. PubMed ID: 9295021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal.
    Menier C; Riteau B; Carosella ED; Rouas-Freiss N
    Int J Cancer; 2002 Jul; 100(1):63-70. PubMed ID: 12115588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis.
    Borrego F; Ulbrecht M; Weiss EH; Coligan JE; Brooks AG
    J Exp Med; 1998 Mar; 187(5):813-8. PubMed ID: 9480992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.